Effect of combined therapy with ansamycin, clofazimine, ethambutol, and isoniazid for Mycobacterium avium infection in patients with AIDS.
Agins
B D
BD
Infectious Disease Section, New York Veterans Administration Medical Center, New York City.
Berman
D S
DS
Spicehandler
D
D
el-Sadr
W
W
Simberkoff
M S
MS
Rahal
J J
JJ
D000386:AIDS-Related Complex / Q000150:complications*; D000163:Acquired Immunodeficiency Syndrome / Q000150:complications*; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000995:Antitubercular Agents / Q000627:therapeutic use*; D002991:Clofazimine / Q000627:therapeutic use; D004977:Ethambutol / Q000627:therapeutic use; D006801:Humans; D007538:Isoniazid / Q000627:therapeutic use; D047029:Lactams, Macrocyclic; D015269:Mycobacterium avium Complex / Q000187:drug effects; D015270:Mycobacterium avium-intracellulare Infection / Q000150:complications / Q000188:drug therapy*; D012141:Respiratory Tract Infections / Q000150:complications / Q000188:drug therapy; D012189:Retrospective Studies; D018805:Sepsis / Q000150:complications / Q000188:drug therapy
D000900:Anti-Bacterial Agents; D000995:Antitubercular Agents; D047029:Lactams, Macrocyclic; D004977:Ethambutol; D002991:Clofazimine; D007538:Isoniazid